# Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction

Study · id `cardio:ct-nct02053493` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02053493](<https://clinicaltrials.gov/study/NCT02053493>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02053493

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 110 participants.

## Technical summary

Registry record NCT02053493. Randomized; triple masking; primary purpose treatment. Start 2014-04 (registry gives no type); primary completion 2015-02 (actual). Results posted on 2016-11-28.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 110 participants (enrolled count; ClinicalTrials.gov record NCT02053493, source copy `cardio:ctgov-nct02053493-2016-11-28`, retrieved 2026-10-26)
- Start date: 2014-04 (registry gives no type) (ClinicalTrials.gov record NCT02053493, source copy `cardio:ctgov-nct02053493-2016-11-28`, retrieved 2026-10-26)
- Primary completion: 2015-02 (actual) (ClinicalTrials.gov record NCT02053493, source copy `cardio:ctgov-nct02053493-2016-11-28`, retrieved 2026-10-26)
- Completion: 2015-03 (actual) (ClinicalTrials.gov record NCT02053493, source copy `cardio:ctgov-nct02053493-2016-11-28`, retrieved 2026-10-26)
- Results first posted: 2016-11-28 (ClinicalTrials.gov record NCT02053493, source copy `cardio:ctgov-nct02053493-2016-11-28`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT02053493, source copy `cardio:ctgov-nct02053493-2016-11-28`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02053493-2016-11-28`, retrieved 2026-10-26)

## The registry's words

- Brief title: Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
- Acronym: NEAT-HFpeF
- Condition: Heart Failure
- Intervention (Drug): Isosorbide Mononitrate
- Intervention (Drug): Placebo
- Lead sponsor: Adrian Hernandez
- Lead sponsor class: OTHER
- Collaborator: National Heart, Lung, and Blood Institute (NHLBI)
- Collaborator class: NIH
- Collaborator: Mayo Clinic
- Collaborator class: OTHER
- Collaborator: University of Vermont
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as a collaborator: National Heart, Lung, and Blood Institute (`cardio:nhlbi`)
- Registry lists this organization as a collaborator: Mayo Clinic (`cardio:org-mayo-clinic`)
- Registry lists this organization as a collaborator: University of Vermont (`cardio:org-university-of-vermont`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Isosorbide Mononitrate in Heart Failure with Preserved Ejection Fraction (`cardio:pubmed-26549714`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Accelerometer-Measured Daily Activity in Heart Failure With Preserved Ejection Fraction: Clinical Correlates and Association With Standard Heart Failure Severity Indices (`cardio:pubmed-28588021`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: ab3b58d12cc61c5a9a527c135ad7b602bd106353f3d79eac0cd04a2cd9a9fc0c
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
